Finally, our in vitro and in vivo findings confirm that co-expression of a CD20-directed CCR successfully potentiated the anti-tumor cytotoxicity of CSPG4-CAR T cells in a CCR- and CAR- target antigen-dependent manner. The gene discussed is CSPG4; the disease is neoplasm.